Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to provide pivotal confirmation of efficacy and safety data for 2
doses of indacaterol (150 and 300 µg once daily [od]) in patients with moderate to severe
chronic obstructive pulmonary disease (COPD). Data from this study will be used for the
registration of indacaterol in Japan.